c_Jun (Ab_170) Antibody
- Known as:
- c_Jun (Ab_170) Antibody
- Catalog number:
- E021023-2
- Product Quantity:
- 100ug
- Category:
- Antibodies
- Supplier:
- EnoGene
- Gene target:
- c_Jun (Ab_170) Antibody
Related products to: c_Jun (Ab_170) Antibody
Related articles to: c_Jun (Ab_170) Antibody
- Lung (LCs) and thymic carcinoids (ThCs) belong to thoracic well-differentiated neuroendocrine tumors (NETs), whose therapeutic options for advanced stages are limited. In the era of precision medicine, tyrosine kinase inhibitors (TKIs) remain a key focus of clinical investigation. This review evaluates the evolving role of TKIs in this setting. - Source: PubMed
Publication date: 2026/06/07
Laffi AliceCatania ChiaraDe Pas MartinoLania AndreaVitali EleonoraPapa RiccardoPelosi Giuseppe - Caring for persons living with dementia (PLwD) involves high levels of physical demands and emotional burden that may undermine caregivers' sleep quality. Few studies have examined sleep among African Americans caregivers of PLwD despite their underrepresentation in dementia research and poorer sleep outcomes compared to other racial and ethnic groups. This study examines the relationships between caregiving stressors and sleep and the moderating effect of resilience on these associations among African American caregivers of PLwD. - Source: PubMed
Publication date: 2026/06/07
Wang Fei - Sexual dysfunction associated with psychological reasons is one of the factors impacting unfulfilled marriages. There are limited data on treatment outcomes in this context. The aim of this study was determining the treatment of unconsummated marriage in psychogenic erectile dysfunction in Iranian Couples. - Source: PubMed
Publication date: 2026/06/07
Foroutan Seyed KazemJadid-Milani MaryamLashani ZeynabKhayyamfar Feraidoon - Perspective-taking refers to one's ability to infer one's own and others' mental states. The existing perspective-taking tasks mainly focus on healthy individuals and overlook the potential confounding effect of prompt type. The current study developed a perspective-taking task for social anxiety research by including both ambiguous and unambiguous prompts and a social context. Analysing two community samples with either ambiguous ( = 69) or unambiguous ( = 89) prompts found that both prompts cued self-perspective-taking and other perspective-taking as required. However, while unambiguous prompts cue perspective switching, the ambiguous prompts failed to do so. Thirty-two participants of the two samples completed the tasks with both prompt types and showed no differences in perspective-taking. Findings suggest that the newly developed task measures self-perspective-taking and other perspective-taking as prompted, regardless of prompt type. Furthermore, the unambiguous prompts may be more sensitive and appropriate for measuring perspective switching and offer greater applicability in neural research. - Source: PubMed
Publication date: 2026/06/07
Kumada MaikaChen Junwen - The growing use of continuous glucose monitors (CGMs) and mobile health (mHealth) applications has changed how diabetes is managed, allowing real-time tracking of glycemic patterns and remote clinical decision-making. These technologies also generate large volumes of sensitive health data, raising questions about who owns this information, how it is protected, and under what conditions it may be repurposed for research or commercial objectives. This review examines the regulatory frameworks governing CGM and mHealth data in major jurisdictions, with particular attention to the Health Insurance Portability and Accountability Act (HIPAA) in the United States and the General Data Protection Regulation (GDPR) in the European Union. Significant regulatory gaps exist, particularly for consumer-grade devices and direct-to-consumer mHealth applications that fall outside traditional healthcare data-protection frameworks. Data ownership remains legally ambiguous in most jurisdictions, with patients, healthcare providers, device manufacturers, and app developers each holding competing claims. The secondary use of clinical data for research, while it could materially advance diabetes care, raises ethical concerns around informed consent, data de-identification, and the boundaries between clinical care and commercial exploitation. Emerging approaches, including the European Health Data Space, federated learning, and differential privacy, may help balance data utility with individual rights. The review recommends changes to regulation, industry practice, and consent models aimed at reconciling data-driven diabetes research with patient autonomy and privacy. - Source: PubMed
Publication date: 2026/06/07
Dario Paulo